Annual General Meeting of Merck KGaA, Darmstadt, Germany, Approves Dividend Increase
- Shareholders approve dividend increase of € 0.15 to € 1.20 (+14%)
- Executive Board and Supervisory Board actions approved by asignificant majority
Darmstadt, Germany, April 28, 2017 – Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced that at its 22nd Annual General Meeting held today in Frankfurt am Main, shareholders approved a dividend increase of € 0.15 or 14% to € 1.20 per share. Merck KGaA, Darmstadt, Germany, has thus raised the dividend every year since 2011.
The Annual General Meeting approved the actions of the members of the Executive Board and of the Supervisory Board for fiscal 2016 by a significant majority and approved all of the resolutions, with the exception of agenda item 7. This related to the resolution on the approval of the compensation system for the Executive Board. Although as a Kommanditgesellschaft auf Aktien (corporation with general partners), it is not legally required to do, Merck KGaA, Darmstadt, Germany, presented the compensation system for Executive Board members, which was adapted with effect from January 1, 2017, to the Annual General Meeting for approval. The company takes feedback from its shareholders seriously and will closely analysis the criticism.
More than 1,100 shareholders took part in the Annual General Meeting. When the resolutions were voted on, approximately 82.8 million shares were represented, corresponding to 64.0 % of the approximately 129.2 million shares issued.
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck KGaA, Darmstadt, Germany, generated sales of € 15.0 billion in 66 countries.
Founded in 1668, Merck KGaA, Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck KGaA, Darmstadt, Germany, holds the global rights to the „Merck” name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
Merck KGaA, Darmstadt, Germany, continued its growth trajectory in the second quarter of 2022 despite a challenging environment. Net sales increased by 14.3% compared with the second quarter of 2021 to ...